Floatz logo

Calaspargase Pegol

Carcinoma, Non-Small-Cell Lung (NSCLC)

Pfizerprotein_peptidePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Carcinoma, Non-Small-Cell Lung (NSCLC) cohort.

Asset / SponsorPhaseRating
Tuvonralimab
Tang-Du Hospital
Phase 2CCC

Same molecule, other indications

Calaspargase Pegol is also rated in:

lymphoblastic lymphomaDormant
BB
Indicative ·
70 / 100
View asset →
acute lymphoblastic leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
B-cell adult acute lymphocytic leukemiaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →